{"id":"repevax-non-concomitant","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL450072","moleculeType":"Small molecule","molecularWeight":"140.23"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"REPEVAX is a combination vaccine that contains inactivated diphtheria and tetanus toxoids and pertussis antigens. It works by stimulating the body's immune system to produce antibodies against these pathogens, providing immunity against diphtheria, tetanus, and pertussis.","oneSentence":"REPEVAX is a vaccine that protects against diphtheria, tetanus, and pertussis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:49.163Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Protection against diphtheria, tetanus, and pertussis in individuals 2 years of age and older"}]},"trialDetails":[{"nctId":"NCT01073293","phase":"PHASE3","title":"A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-04-22","conditions":"Papillomavirus Infections","enrollment":1054},{"nctId":"NCT00337428","phase":"PHASE3","title":"Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-05","conditions":"Neoplasms, Glandular and Epithelial, Diphtheria, Tetanus","enrollment":843}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"REPEVAX™ (Non-concomitant)","genericName":"REPEVAX™ (Non-concomitant)","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Biologic","firstApprovalDate":"","aiSummary":"REPEVAX is a vaccine used to prevent diphtheria, tetanus, and whooping cough. It is administered as a small molecule vaccine, and its non-concomitant formulation is used in clinical studies for various conditions, including papillomavirus infections and neoplasms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}